ENCHANTED results challenge reduced alteplase dose in Asian stroke patients

A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
Source: MedWire News - Category: Consumer Health News Tags: Stroke Source Type: news